$0.700000
0.023.70%
At Close: -
$0.720000
0.022.86%
After Hours: Oct 4, 5:28 PM EDT
15 minutes delayed
INVO Bioscience reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of INVO Bioscience using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-14 | $-3.06 | $-4.20 | 27.1 % |
Mar 2023 | 2023-04-17 | $-4.60 | $-3.80 | -2105.3 % |
Sep 2022 | 2022-11-14 | $-4.20 | $-2.60 | -6153.9 % |
Jun 2022 | 2022-08-15 | $-4.60 | $-4.80 | 416.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2023 | 2023-08-14 | $315.90K | $2.96M | -89.3 % |
Mar 2023 | 2023-04-17 | $278.14K | $260.00K | 6.98 % |
Sep 2022 | 2022-11-14 | $235.32K | $500.00K | -52.9 % |
Jun 2022 | 2022-08-15 | $146.14K | $330.00K | -55.7 % |
INVO Bioscience (INVO) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.62, which missed the estimate of $0.00.
The Actual Revenue was $1.8M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.